Search

Astellas Pharma Inc.
  • Top MenuAbout
    • Philosophy
    • Vision & Strategy
    • Group Code of Conduct
    • Astellas Pharma Israel
    • Policies & Position Statements
    • Ethics & Compliance
    • Transparency
    • Making an Impact
    • Support for Medical Education
  • Top MenuTherapy Areas
    • Therapy Areas
      • Urology
      • Oncology / Haematology
      • Transplantation
      • Women’s Health
    • Astellas Products
      • BETMIGA™ (mirabegron)
      • XTANDI™ (enzalutamide)
      • XOSPATA™ (gilteritinib)
      • ADVAGRAF™ (tacrolimus prolonged release)
      • PROGRAF™ (tacrolimus)
      • PADCEV™ (enfortumab vedotin)
      • VEOZA™ (fezolinetant)
  • Top MenuInnovation
    Clinical Trials
    Astellas has established a website to disclose information obtained from Astellas-sponsored clinical trials…
    לקריאה נוספת
    • R & D
      • Clinical Trials
      • Approach
      • Ethics & Principles
    • Pipeline
    • Investigator Sponsored Research
  • Top MenuSustainability
    Access to Health
    Advances continue to be made in technology and medicine that address unmet medical needs. However, there still remain barriers for many people…
    לקריאה נוספת
    • Global Sustainability Policy
    • Sustainability Approach
    • Access to Health
    • Environment
    • Modern Slavery Act
    • Gender Pay Gap Report
  • Top MenuNews
    Media Contacts
    The Astellas Corporate Communications team will respond to calls and emails from journalists. For general media enquiries, please email contact_uk...
    לקריאה נוספת
    • News
    • Media Contacts
    • Social Media Code of Conduct

Common header menu

  • CONTACT US
  • CAREERS
  • WORLDWIDE
  • ISRAEL
  • WORLDWIDE - ISRAEL
  • English
  • עברית
  1. Home
  2. Sustainability

Sustainability

Access to Health

Access to Health

Sustainability Approach

Sustainability Approach

Global Sustainability Policy

Global Sustainability Policy

Gender Pay Gap Report

Gender Pay Gap Report

Modern Slavery Act

Modern Slavery Act

Environment

Environment

MAT-IL-NON-2023-00001

LogoSolgan

Follow us on social media

linkedin_icon X logo-white-footer

Bottom footer menu

  • SITE MAP
  • PRIVACY NOTICE
  • TERMS OF USE
  • COOKIES POLICY
© 2024 Astellas Pharma Inc.

Update cookie preference